HCPCS Level II
J0873
Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
Codes near J0873
These sit next to J0873 in the CMS Level II file. All J codes
- J0841Injection, crotalidae immune f(ab')2 (equine), 120 mg
- J0850Injection, cytomegalovirus immune globulin intravenous (human), per vial
- J0870Injection, imetelstat, 1 mg
- J0871Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg
- J0872Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
- J0874Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg
- J0875Injection, dalbavancin, 5 mg
- J0877Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg
- J0878Injection, daptomycin, 1 mg
- J0879Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00143-9455-01 | Daptomycin | Hikma Pharmaceuticals USA Inc. | 350 |
| 70594-0053-01 | Daptomycin | Xellia Pharmaceuticals USA, LLC. | 350 |
| 72572-0100-01 | Daptomycin | Civica, Inc. | 350 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.
Run it in Rivvi
Check every code on your export
Upload a claims or problem-list export. Rivvi flags codes that are not billable, replaced, or unspecified when a specific code exists.
Check my exportFree to start. Opens Rivvi, the AI workspace for healthcare teams.